共 50 条
- [43] COMPLICATIONS ASSOCIATED WITH INVIVO ADMINISTRATION OF ANTI-CEA MURINE MONOCLONAL-ANTIBODIES IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 217 - 217
- [46] FACTORS AFFECTING IN-111 LABELED ANTI-CEA MONOCLONAL-ANTIBODY (INDACEA) BIODISTRIBUTION AND IMAGING - TUMOR CEA CONTENT AND TUMOR SIZE TUMOUR BIOLOGY, 1985, 6 (04): : 356 - 356
- [48] IMMUNOSCINTIGRAPHY IN MEDULLARY-THYROID CANCER USING AN LABELED-I-123 OR IN-111 LABELED MONOCLONAL ANTI-CEA ANTIBODY FRAGMENT NUCLEAR MEDICINE-NUKLEARMEDIZIN, 1986, 25 (06): : 227 - 231
- [50] USE AND LIMITATIONS OF I-131-LABELED MONOCLONAL ANTI-CEA ANTIBODIES FOR SCANNING DETECTION OF HUMAN CARCINOMAS ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1981, 2 (05): : P28 - P28